The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.The move to authorize the shots comes as Covid-19 infections in the U.S. tick up amid the most intense flu season in years.
The FDA on Thursday authorized emergency use of updated bivalent Covid-19 vaccines for children as young as 6 months old.
The move to authorize bivalent shots made by Pfizer-BioNTech and Moderna comes as Covid-19 infections in the United States tick up amid the most intense flu season in years.
“Parents and caregivers can be assured that the FDA has taken a great deal of care in our review, and we encourage parents of children of any age who are eligible for primary vaccination or a bivalent COVID-19 vaccine booster dose to consider seeking vaccination now as it can potentially help protect them from COVID-19 during a time when cases are increasing,” top FDA vaccine regulator Peter Marks said in a statement.
The agency’s Advisory Committee on Immunization Practices was slated to meet Friday, however the meeting — which did not have an agenda disclosed — has been postponed, according to the committee’s website.
